Table 1 (abstract A29).
See text for description
| Characteristic | Proportion or Summary Statistic |
|---|---|
| Age (mean (sd)) | 7.0 (4.5) |
| Female (%) | 40% |
| White Race (%) | 68% |
| Black Race (%) | 11% |
| Other Race (%) | 22% |
| Elapsed Days Since Onset of Symptoms (mean (sd)) | 40 (46) |
| Elapsed Days Since Diagnosis (mean (sd)) | 6 (8) |
| Physician Global Assessment (mean (sd)) | 5.9 (2.2) |
| Parent Global Assessment (mean (sd)) | 5.1 (3.3) |
| Number of Active Joints (mean (sd)) | 6.4 (8.0) |
| sJIA rash (%) | 85% |
| Generalized lymphadenopathy (%) | 25% |
| Hepatomegaly (%) | 15% |
| Splenomegaly (%) | 15% |
| Serositis (%) | 13% |
| Morning Stiffness >15 minutes (%) | 37% |
| ESR (median (IQR)) | 71 (44-100) |
| C-RP (median (IQR)) | 12.3 (6.2-53.3) |
| Ferritin (median (IQR)) | 700 (236-1266) |
| Hemoglobin (median (IQR)) | 10.1 (9.1-11.1) |
| WBC (median (IQR)) | 14.7 (9.8-20.2) |
| Platelets (median (IQR)) | 453 (335-564) |
| AST (median (IQR)) | 34 (23-46) |
| ALT (median (IQR)) | 33 (16-51) |
| CHAQ (mean (sd)) | 1.1 (0.9) |
| Pain VAS (mean (sd)) | 2.9 (2.7) |
Characteristics of Participants in FROST at study enrollment (N=40)